Home > Coronavirus/COVID-19 > State and federal offices seek to protect consumers by cracking down on false and misleading COVID-19 treatment claims

State and federal offices seek to protect consumers by cracking down on false and misleading COVID-19 treatment claims

Earlier this month the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) jointly issued warning letters to seven companies for selling products that fraudulently claim to prevent, treat or cure COVID-19. The products cited in these warning letters are teas, essential oils, tinctures and colloidal silver, all of which FDA considers unapproved drugs that pose significant risks to patient health and violate federal law. READ MORE